A Phase I/II Study of M3814 and Avelumab in Combination with Hypofractionated Radiation in Patients with Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies

Brief description of study

A Phase I/II Study of M3814 and Avelumab in Combination with Hypofractionated Radiation in Patients with Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies


Clinical Study Identifier: s20-01391
ClinicalTrials.gov Identifier: NCT04068194


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.